# Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

> **NCT01530763** · PHASE2,PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 161 (actual)

## Conditions studied

- Infections
- Community Acquired Pneumonia

## Interventions

- **DRUG:** Ceftaroline fosamil
- **DRUG:** Ceftriaxone
- **DRUG:** amoxicillin clavulanate

## Key facts

- **NCT ID:** NCT01530763
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-07
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2015-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01530763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01530763, "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01530763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*